Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides
Disease Models & Mechanisms · 01.05.2026 · 19 (5)
DOI: 10.1242/dmm.052729 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 18.05.2026. Verfasst von Marta Marzullo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Biotechnologies 'C. Darwin', Sapienza University of Rome, 00185 Rome, Italy. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Peptides, Codon, Initiator, Repetitive Sequences, Amino Acid. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Universite e della Ricerca, Fondazione Telethon, AFM-Téléthon.
Abstract (Originalsprache)
Myotonic dystrophy type 2 (DM2) is an autosomal dominant, multisystemic disorder caused by the expansion of CCTG repeats in the first intron of the CNBP gene. Repeat-associated non-AUG (RAN) translation of the expanded CCTG RNA generates two tetrapeptide repeat proteins, polyQAGR and polyLPAC, but their roles in DM2 pathogenesis remain unclear. To define their individual contributions, we expressed codon-optimized polyQAGR and polyLPAC peptides with an ATG start codon in Drosophila melanogaster. Expression of both tetrapeptide repeat proteins reduced viability and lifespan and induced eye degeneration and locomotor defects. We found that polyQAGR accumulated in the nucleolus, disrupted nucleolar integrity and impaired rRNA processing. It also interfered with autophagy, promoting Atg5 and Atg7 transcription and accumulation of Atg8a- and Ref(2)P-positive aggregates. Overexpression of Atg8a or Ref(2)P mitigated polyQAGR-induced eye toxicity, whereas knockdown of autophagy genes worsened it. Conversely, PolyLPAC expression increased the cytoplasmic pool of TIAR in human cells and in DM2 patient-derived myoblasts. Together, these findings show that polyQAGR and polyLPAC exert distinct toxic effects that likely converge to drive DM2 pathogenesis and may represent promising therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology and Biotechnologies 'C. Darwin', Sapienza University of Rome, 00185 Rome, Italy.
- Institute of Molecular Biology and Pathology, National Research Council (IBPM, CNR), c/o Department of Biology and Biotechnologies 'C. Darwin', Sapienza University of Rome, 00185 Rome, Italy.
- Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
ORCID-Profile: Marta Marzullo, Marta Terribili, Michela Di Salvio, Degisew Yinur Mengistu, Maria Patrizia Somma, Gianluca Canettieri, Gianluca Cestra, Laura Ciapponi
Förderung
- Ministero dell'Universite e della Ricerca
- Fondazione Telethon
- AFM-Téléthon
- Ministero dell'Università e della Ricerca
Zitieren
APA
Marzullo, M., De Simone, A., Terribili, M., Di Salvio, M., Mengistu, D. Y., Somma, M. P., D'Amico, R., Canettieri, G., Cestra, G., & Ciapponi, L. (2026). Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides. Disease Models & Mechanisms, 19(5). https://doi.org/10.1242/dmm.052729
Vancouver
Marzullo M, De Simone A, Terribili M, Di Salvio M, Mengistu DY, Somma MP, et al. Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides. Disease Models & Mechanisms. 2026;19(5). doi:10.1242/dmm.052729
BibTeX
@article{Marzullo2026,
author = {Marzullo, Marta and De Simone, Assia and Terribili, Marta and Di Salvio, Michela and Mengistu, Degisew Yinur and Somma, Maria Patrizia and D'Amico, Rodrigo and Canettieri, Gianluca and Cestra, Gianluca and Ciapponi, Laura},
title = {Distinct cellular effects of myotonic dystrophy type 2 repeat-associated non-AUG tetrapeptides},
journal = {Disease Models & Mechanisms},
year = {2026},
volume = {19},
number = {5},
doi = {10.1242/dmm.052729}
}
EUVIMED